Nifty Pharma index declined 1.5 per cent in trade after US President Donald Trump warned to impose a 25 per cent tariff on ...

The group acknowledges limited growth in South Africa’s price-regulated pharma market but believes Natco’s backing will ...

Some stocks in the Nifty 500 have shown early signs of momentum, but they are still flying under the radar with weekly relative strength index (RSI) below 70. SEBI-registered analyst Mayank Singh ...

Natco Pharma on July 23 said it will buy 35.75% stake in South Africa's Adcock Ingram for Rs 2,000 crore. Natco Pharma to set ...

Hyderabad: NATCO Pharma Limited has submitted a firm intention offer to Adcock Ingram Holdings Limited, a South African ...

Adcock Ingram offers generics and OTC medicines in Africa. CNBC-Awaaz reported that Natco may buy majority stake in the firm ...

Natco Pharma to acquire 35.75% stake in South Africa’s Adcock Ingram for ₹1,970 crore in cash; move aimed at expanding global ...

The deal will still see Bidvest as the majority shareholder but will mean that the SA pharmaceutical group will be delisted ...

Stock Market Today: Natco Pharma share price gained more than 7% to scale 52 week highs on Thursday during the intraday trades. The robust US sales growth led by Revlimid generics is driving earnings.

Should the offer be accepted, the company will hold a 35.75 per cent stake in the South Africa firm, valued at R4 billion ...

Natco Pharma to acquire 35.75% stake in South Africa's Adcock Ingram for Rs 2,000 crore, marking its entry into the African ...

Natco Pharma Ltd. on Wednesday, July 23, announced the acquisition of a 35.75% stake in South Africa-based Adcock Ingram ...